ZD6474-凡德他尼 Vandetanib_蛋白酪氨酸激酶-MedChemExpress LLC

联系我们时请说明是91化工仪器网上看到的信息，谢谢!

详细介绍 Vandetanib

产品活性：Vandetanib是有效的 VEGFR2 抑制剂，IC50 为40 nM。

研究领域：Protein Tyrosine Kinase/RTK | Autophagy

作用靶点：VEGFR | Autophagy

In Vitro: Vandetanib inhibits VEGFR3 and EGFR with IC50 of 110 nM and 500 nM, respectively. Vandetanib is not sensitive to PDGFRβ, Flt1, Tie-2 and FGFR1 with IC50 of 1.1-3.6 μM, while almost has no activity against MEK, CDK2, c-Kit, erbB2, FAK, PDK1, Akt and IGF-1R with IC50 above 10 μM. Vandetanib inhibits VEGF-, EGF- and bFGF-stimulated HUVEC proliferation with IC50 of 60 nM, 170 nM and 800 nM, with no effect on basal endothelial cell growth. Vandetanib inhibits tumor cell growth with IC50 of 2.7 μM (A549) to 13.5 μM (Calu-6). Odanacatib is a weak inhibitor of antigen presentation, measured in a mouse B cell line (IC50=1.5 0.4 μM), compared to the Cat S inhibitor LHVS (IC50=0.001 μM) in the same assay. Odanacatib also shows weak inhibition of the processing of the MHC II invariant chain protein Iip10 in mouse splenocytes compared to LHVS (minimum inhibitory concentration 1-10 μM versus 0.01 μM, respectively). Vandetanib suppresses phosphorylation of VEGFR-2 in HUVECs and EGFR in hepatoma cells and inhibits cell proliferation.

In Vivo: Vandetanib (15 mg/kg, p.o.) has a superior anti-tumor effect than gefitinib in the H1650 xenograft model, and suppresses tumor growth with IC50 of 3.5 1.2 μM. In tumor-bearing mice, vandetanib (50 or 75 mg/kg) suppresses phosphorylation of VEGFR-2 and EGFR in tumor tissues, significantly reduces tumor vessel density, enhances tumor cell apoptosis, suppresses tumor growth, improves survival, reduces number of intrahepatic metastases, and upregulates VEGF, TGF-α, and EGF in tumor tissues.

相关产品：FDA-Approved Drug Library Plus | Drug Repurposing Compound Library | FDA-Approved Drug Library Mini | Kinase Inhibitor Library | CNS-Penetrant Compound Library | FDA-Approved Drug Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Drug Repurposing Compound Library Plus | Bioactive Compound Library Plus | Autophagy Compound Library | Sorafenib | Lenvatinib | Nintedanib | Regorafenib | Cabozantinib | Ponatinib | Sunitinib | Semaxinib | Bevacizumab | Apatinib | Pazopanib | Axitinib | PD173074 | Foretinib | SU 5402 | RAF265 | Linifanib | Cediranib | Lucitanib | Sitravatinib | BMS-690514 | Gandotinib | Tivozanib | Dovitinib | 5Z-7-Oxozeaenol | PF-03814735

以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，91化工仪器网对此不承担任何保证责任。
温馨提示：为规避购买风险，建议您在购买产品前务必确认供应商资质及产品质量。 搜本商铺 或 搜全站

MedChemExpress LLC - 主营产品： 西罗莫司 Rapamycin,瑞沙托维 TAK-242,奥拉帕尼 Olaparib

地址：上海市浦东新区张衡路1999弄3号楼      联系电话：86-021-58955995      手机：18019480960     传真：86-021-53700325
91化工仪器网 设计制作，未经允许翻录必究 .      Copyright(C) http://www.chem17.com,      All rights reserved. 以上信息由企业自行提供，信息内容的真实性、准确性和合法性由相关企业负责，91化工仪器网对此不承担任何保证责任。
温馨提示：为规避购买风险，建议您在购买产品前务必确认供应商资质及产品质量。
会员登录